In literature, PYCR1 interference has been shown to decrease p-AKT levels in bladder cancer cell lines [39], papillary renal cell carcinoma [44] and in melanoma [43], while it also reduces cell growth in hepatocellular cancer cell lines [28]. This evidence concerns the gene PYCR1 and papillary renal cell carcinoma.